Delivery Order SPE2DB24D1205-SPE2DB24FCTVL

Award Date 8/16/24
Potential Completion Date 8/19/24
Potential Value $6.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of RINVOQ ER 30 MG TABLET UU 30S. The contract has a firm fixed price of $9,629.24 and a period of performance through June 24, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical,...
This is a Delivery Order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of RINVOQ ER 15 MG TABLET, a medication, with a ceiling value of $11,886.85 and a completion date of June 13, 2025. The contract is a Firm Fixed Price arrangement without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 15 MG TABLET. The contract has a firm fixed price of $29,216.09 and a completion date of March 18, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set-aside, has a ceiling value of $25,666.60 and a completion date of June 18, 2025. The contract provides for the delivery of RINVOQ ER 15 MG TABLET, a pharmaceutical product. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 30 MG TABLET, a medication, with a ceiling value of $15,393.16 and a completion date of July 8, 2025. The contract is firm fixed price and is not set aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order issued under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $999,999,999 through December 2025, is for the supply of a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities and programs worldwide. The specific delivery order, valued at $7,068.48, is for the supply of RINVOQ ER 15 MG TABLET, a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication RINVOQ ER 30 MG TABLET. The contract has a firm fixed price of $9,334.95 and a completion date of July 7, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00. This IDC serves as a comprehensive global pharmaceutical support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET, a pharmaceutical product, with a ceiling value of $13,553.10 and a performance period ending on June 10, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corporation holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,223.32 firm fixed-price contract is for the procurement of Rinvoq ER 15 mg tablets, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $82,926.33 contract is for the delivery of RINVOQ ER 30 MG TABLET, a prescription medication. The contract has an ultimate completion date of July 1, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCTVL
    Delivery Order

This contract is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the purchase of RINVOQ ER 15 MG Tablets. The order has a firm fixed price of $6,107.22 and an ultimate completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/15/24, 9:14 AM